235 related articles for article (PubMed ID: 23636170)
21. Protein-bound uremic solutes: the forgotten toxins.
Vanholder R; De Smet R; Lameire N
Kidney Int Suppl; 2001 Feb; 78():S266-70. PubMed ID: 11169024
[TBL] [Abstract][Full Text] [Related]
22. Protein-bound uremic toxins - biological effects and impact on morbidity in patients with chronic kidney disease.
Gomółka M; Niemczyk S
Przegl Lek; 2017; 74(3):110-4. PubMed ID: 29694770
[TBL] [Abstract][Full Text] [Related]
23. Phenyl sulfate, indoxyl sulfate and p-cresyl sulfate decrease glutathione level to render cells vulnerable to oxidative stress in renal tubular cells.
Edamatsu T; Fujieda A; Itoh Y
PLoS One; 2018; 13(2):e0193342. PubMed ID: 29474405
[TBL] [Abstract][Full Text] [Related]
24. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
[TBL] [Abstract][Full Text] [Related]
25. Protein-bound uremic retention solutes.
Brunet P; Dou L; Cerini C; Berland Y
Adv Ren Replace Ther; 2003 Oct; 10(4):310-20. PubMed ID: 14681860
[TBL] [Abstract][Full Text] [Related]
26. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
[TBL] [Abstract][Full Text] [Related]
27. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
[TBL] [Abstract][Full Text] [Related]
28. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.
Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P
Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619
[TBL] [Abstract][Full Text] [Related]
29. Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.
Prokopienko AJ; Nolin TD
Expert Rev Clin Pharmacol; 2018 Jan; 11(1):71-82. PubMed ID: 28905671
[TBL] [Abstract][Full Text] [Related]
30. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
[TBL] [Abstract][Full Text] [Related]
31. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
Huang WH; Hung CC; Yang CW; Huang JY
Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney disease.
Prokopienko AJ; West RE; Stubbs JR; Nolin TD
J Pharm Biomed Anal; 2019 Sep; 174():618-624. PubMed ID: 31276982
[TBL] [Abstract][Full Text] [Related]
33. The removal of protein-bound solutes by dialysis.
Meyer TW
J Ren Nutr; 2012 Jan; 22(1):203-6. PubMed ID: 22200443
[TBL] [Abstract][Full Text] [Related]
34. New insights into uremic toxicity.
Raff AC; Meyer TW; Hostetter TH
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):560-5. PubMed ID: 18941347
[TBL] [Abstract][Full Text] [Related]
35. Impaired Tubular Secretion of Organic Solutes in Acute Kidney Injury.
O'Brien FJ; Mair RD; Plummer NS; Meyer TW; Sutherland SM; Sirich TL
Kidney360; 2020 Aug; 1(8):724-730. PubMed ID: 35252876
[TBL] [Abstract][Full Text] [Related]
36. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.
Sirich TL; Plummer NS; Gardner CD; Hostetter TH; Meyer TW
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1603-10. PubMed ID: 25147155
[TBL] [Abstract][Full Text] [Related]
37. Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injury.
André C; Bennis Y; Titeca-Beauport D; Caillard P; Cluet Y; Kamel S; Choukroun G; Maizel J; Liabeuf S; Bodeau S
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122234. PubMed ID: 32615535
[TBL] [Abstract][Full Text] [Related]
38. Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate.
Meyer TW; Peattie JW; Miller JD; Dinh DC; Recht NS; Walther JL; Hostetter TH
J Am Soc Nephrol; 2007 Mar; 18(3):868-74. PubMed ID: 17251385
[TBL] [Abstract][Full Text] [Related]
39. Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles.
Kalim S; Wald R; Yan AT; Goldstein MB; Kiaii M; Xu D; Berg AH; Clish C; Thadhani R; Rhee EP; Perl J
Clin J Am Soc Nephrol; 2018 Mar; 13(3):436-444. PubMed ID: 29444900
[TBL] [Abstract][Full Text] [Related]
40. Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry.
Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1662-8. PubMed ID: 20036201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
